Shanghai Pharma Gains Approval For Asset Restructuring
This article was originally published in PharmAsia News
Executive Summary
Shanghai Pharmaceutical recently gained full approval from regulatory authorities for a merger with Shanghai Industrial Pharmaceutical Investment and Shanghai Zhongxi Pharmaceutical